【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, January 2014 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, January 2014 14
2.2.1 McKesson Completes Acquisition of Celesio for US$8.49 Billion 14
2.2.2 Edison Pharma Expands Licensing Agreement with Dainippon Sumitomo Pharma 15
2.2.3 Community Health Systems Completes Private Placement of Notes for US$4 Billion 16
2.2.4 Forest Lab Completes Acquisition of Aptalis Pharma from TPG Capital for US$2.9 Billion 17
2.2.5 Bayer Announces Public Offering of Bonds for US$2.7 Billion 18
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, January 2014 19
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, January 2014 20
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21
3.1 Pharmaceuticals & Healthcare, Global, M&A, January 2014 21
3.1.1 Top M&A Deals in January 2014 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, August 2013 – January 2014 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, January 2014 24
3.2.1 Top Equity Offering Deals in January 2014 25
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, August 2013 – January 2014 26
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, January 2014 27
3.3.1 Top PE/VC Deals in January 2014 28
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, January 2014 29
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, January 2014 30
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, August 2013-January 2014 32
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, August 2013-January 2014 33
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, January 2014 34
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, January 2014 34
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, August 2013 – January 2014 36
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), January 2014 37
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, January 2014 38
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), August 2013 – January 2014 39
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, August 2013 – January 2014 41
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), August 2013 – January 2014 42
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), August 2013 – January 2014 44
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, January 2014 46
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, January 2014 46
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), January 2014 48
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, January 2014 49
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, January 2014 50
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, January 2014 50
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), August 2013 – January 2014 51
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), August 2013 – January 2014 53
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), August 2013 – January 2014 55
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), August 2013 – January 2014 57
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 59
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, January 2014 59
6.1.1 Oncology – Deals of the Month 60
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, January 2014 62
6.2.1 Central Nervous System – Deals of the Month 63
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, January 2014 66
6.3.1 Infectious Diseases – Deals of the Month 67
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, January 2014 69
6.4.1 Metabolic Disorders – Deal of the Month 70
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, January 2014 72
6.5.1 Immunology – Deal of the Month 73
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, January 2014 74
6.6.1 Cardiovascular – Deal of the Month 75
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, January 2014 77
6.7.1 Gastrointestinal – Deals of the Month 78
7 Deal Summary by Geography 79
7.1 Pharmaceuticals & Healthcare, North America Deals, January 2014 79
7.1.1 North America – Deals of the Month 80
7.2 Pharmaceuticals & Healthcare, Europe, Deals, January 2014 82
7.2.1 Europe – Deals of the Month 83
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, January 2014 85
7.3.1 Asia-Pacific – Deals of the Month 86
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, January 2014 88
7.4.1 Rest of the World – Deals of the Month 89
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 90
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, August 2013 – January 2014 90
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, August 2013 – January 2014 92
9 Further Information 93
9.1 Methodology 93
9.2 About GlobalData 94
9.3 Disclosure information 95
9.4 Disclaimer 95
【レポート販売概要】
■ タイトル：グローバル製薬業界における事業提携、ライセンシング、投資及びM&A動向：2014年1月■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for January 2014 in Pharmaceuticals
■ 発行日：2014年3月19日
■ 調査会社：GlobalData
■ 商品コード：GDPH0447MD
■ 調査対象地域：グローバル
- ビジネスインフォメーションの世界市場2017-2021Business information services and solutions can be defined as systems, which provide syndicated information, trade publishing, and advisory services for decision-making in industries such as the finance, legal, media, healthcare, and scientific research. The business information solutions collect, process, and disseminate information. Technavio’s analysts forecast the global business information m …
- 超音速ビジネスジェット（SBJ）の世界市場2016-2020About Supersonic Business Jet A supersonic business jet (SBJ) is a small business private carrier, which can accommodate 10 to 12 passengers and can fly at a speed of more than Mach 1. It efficiently reduces the travel time to half, as compared to other conventional business aircraft. Currently, aviation experts such as Airbus, Lockheed Martin, Aerion, HyperMach, and Gulfstream Aerospace develop s …
- LTEブロードキャスト：モバイルビデオ及びTV分野のゲーム・チェンジャー（LTE Broadcast: Global Market Game Changer for Mobile Video and TV in the post-4G World）With the introduction of LTE-enabled high bandwidth, video has become easier to download and stream. While mobile communications, particularly smartphones, tablets, and other wireless devices have gained significant penetration in recent years, data consumption remains relatively low. However, it is important to note that with only about ten percent of mobile subscribers using video, it represents …
- 世界のPaaS市場Most of the companies worldwide are looking at standardizing their operations through cloud computing. In the cloud computing arena PaaS (Platform as a Service) has made its mark in recent years with a subsequent growth. PaaS in cloud computing provides a computing platform and a solution stack, which allows consumers to create software using tools and libraries from the provider. This concept of …
- グローバルにおける女性医療（リプロダクティブ・ヘルス）市場（2014-2018）About Women’s Health Women experience physiological and emotional issues during different phases of their life cycle due to hormonal changes. Women's health is especially referred to where reproductive health is involved. According to the Society for Women's Health Research in the US, issues specific to the human female anatomy are defined as women's health. The biological mechanisms influence the …
- 世界のヘリコバクター・ピロリ検査市場The report presents a detailed analysis of the Helicobacter Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals …
- ホルモン補充療法（HRT）の世界市場：エストロゲン補充療法、成長ホルモン補充療法[Global Hormone Replacement Therapy Market 2015-2019] Covering: An in-depth study of the global hormone replacement therapy market and segmentation by type of hormonal therapy (estrogen replacement therapy and growth hormone replacement therapy), by route of administration (oral, parenteral, and transdermal), and by geography (the Americas, EMEA, and APAC). The report also presents the vendor land …
- 低出力電動バイクおよびスクーターの世界市場：車両別、地域別Global Low-powered Electric Motorcycle and Scooter Market: About this market Technavio’s low-powered electric motorcycle and scooter market analysis considers sales from electric scooters and electric motorcycles. Our study also finds the sales of low-powered electric motorcycle and scooter in APAC, Europe, MEA, North America, and South America. In 2019, the electric scooters segment had a signifi …
- 生体認証センサーの世界市場分析：製品別（容量性センサー、光学センサー、熱センサー、超音波センサー、電界センサー）、用途別（音声スキャン、指スキャン、手スキャン、顔面スキャン、虹彩スキャン、静脈スキャン）、エンドユーザー別（消費者家電、商業ビルディング、防衛、医療、BFSI）、セグメント予測The global Biometric Sensor Market size is expected to reach USD 1.83 billion by 2024, according to a new report by Grand View Research, Inc. Technological proliferation and increasing demand in commercial buildings, consumer electronics, and banking applications are expected to drive the market growth. The development of advanced multimodal techniques for biometric authentication and recognition …
- 感圧ラベルの世界市場2016-2020About Pressure Sensitive Labels Pressure sensitive labels in product packaging act as sources of information on pack contents, help in locating products through barcodes, tracking, tracing and authentication of devices and are also useful for promotion and decoration. Pressure sensitive labels are a valuable and easily accessible marketing tool that helps manufacturers to apply labels directly on …
- タイヤ物流の世界市場ABSTRACTAbout Tire Logistics Logistics and supply chains for spare parts are unstable when compared with market finished products. Many manufacturing companies are facing setbacks because of an increase in operational costs and a decline in demand from consumers. Vendors of logistics services need to be efficient at services such as data management, IT, and supply chain management. Accurate foreca …
- 防汚塗料の世界市場：船舶、リグ用途About Antifouling Coatings Antifouling coatings are paints or coatings applied to the hull of a boat, ship, or yacht to reduce the growth of organisms on the part of the ship that is under water and to prevent corrosion of metal hulls. The application of such coatings improves the durability and performance of the vessel. In addition, antifouling coatings are used in fixed and floating offshore oi …
- UK Hospital Coagulation Testing Market 2014This new report from Venture Planning Group contains 402 pages, 28 tables, and presents a comprehensive analysis of the UK hospital coagulation testing market, including: Major issues pertaining to the UK coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and …
- 世界のデータガバナンス市場：コンポーネント別、展開モデル別、組織規模別、用途別（リスク管理、インシデント管理、コンプライアンス管理）、業種別（製造、ヘルスケア、BFSI）、地域別The global data governance market size to grow at a CAGR of 21.5% during the forecast period The data governance market size is projected to grow from USD 1.8 billion in 2019 to USD 4.8 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 21.5% during the forecast period. The data governance market is driven by growing regulatory compliance and privacy concerns for data security. However, t …
- POC（ポイントオブケア）血液凝固検査の世界市場2018-2022About Point-of-Care Coagulation Testing POC coagulation testing involves the use of devices and instruments for monitoring coagulation at hospitals, clinics, or at patient homes. Measurements of coagulation are important to diagnose blood clotting disorders. Technavio’s analysts forecast the global point-of-care coagulation testing market to grow at a CAGR of 6.11% during the period 2018-2022. Cov …
